{"id":"phentetramine","rwe":[],"tags":[{"label":"phentetramine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"alzaten","offLabel":[],"synonyms":["phentetramine","fentetramine","alzaten","fentetramin","fentetramina"],"timeline":[],"approvals":[],"brandName":"Alzaten","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"phentetramine","explanation":"Imagine your brain is a city with different neighborhoods. Phentetramine is like a key that unlocks certain neighborhoods, allowing more messages to be sent between them. This can help improve communication between different parts of the brain.","oneSentence":"Phentetramine is thought to work by activating certain receptors in the brain to increase the release of neurotransmitters.","technicalDetail":"Phentetramine is a sympathomimetic agent that likely acts as an agonist at adrenergic receptors, increasing the release of norepinephrine and other neurotransmitters."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/2141","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=phentetramine","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:19:17.214729","biosimilars":[],"competitors":[],"genericName":"phentetramine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"CCV19781NW","CHEBI":"CHEBI:135519","KEGG_DRUG":"D08361","PUBCHEM_CID":"86278184"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Neuroscience"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Alzaten, also known as phentetramine, is a small molecule drug in the phentetramine class. Unfortunately, there is limited information available on this compound. It is not clear what specific target it binds to or what indications it is approved for. Alzaten's commercial status and safety considerations are also unknown. Further research is needed to fully understand this compound.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}